No results for ‘’
Bliss GVS Pharma Ltd
₹295.35
(1.83%)
Sun, 31 May 2026, 03:50 am
Health Technology
Pharmaceuticals: Major
24.5KBliss GVS Pharma Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 35.36 | 35.36 | 35.39 | 35.44 | 35.29 |
| FII | 10.45 | 14.54 | 13.27 | 12.65 | 13.18 |
| DII | 5.04 | 5.78 | 5.98 | 6.54 | 6.55 |
| Public | 49.15 | 44.32 | 45.36 | 45.36 | 44.98 |
| Government | 0 | 0 | 0 | 0 | 0 |
Bliss GVS Pharma Ltd Shareholding Pattern
The Bliss GVS Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bliss GVS Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Bliss GVS Pharma Ltd (NSE: BLISSGVS, BSE: 506197) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bliss GVS Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Bliss GVS Pharma Ltd Shareholding Pattern (Latest)
The latest Bliss GVS Pharma Ltd shareholding for Mar 2026 is:
- Promoters: 35.36%
- FII: 10.45%
- DII: 5.04%
- Public: 49.15%
- Government: 0%
Promoter holding in Bliss GVS Pharma Ltd remains stable, reflecting consistent long-term commitment.
Bliss GVS Pharma Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Bliss GVS Pharma Ltd.
- Mar 2026: 35.36%
- Dec 2025: 35.36%
- Sept 2025: 35.39%
- Jun 2025: 35.44%
- Mar 2025: 35.29%
Promoter stake remains largely stable, showing consistent ownership structure.
Bliss GVS Pharma Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bliss GVS Pharma Ltd.
- Mar 2026: 10.45%
- Dec 2025: 14.54%
- Sept 2025: 13.27%
- Jun 2025: 12.65%
- Mar 2025: 13.18%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Bliss GVS Pharma Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 5.04%
- Dec 2025: 5.78%
- Sept 2025: 5.98%
- Jun 2025: 6.54%
- Mar 2025: 6.55%
DII holdings remain stable, reflecting steady institutional participation.
Bliss GVS Pharma Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 49.15%
- Dec 2025: 44.32%
- Sept 2025: 45.36%
- Jun 2025: 45.36%
- Mar 2025: 44.98%
Public participation in Bliss GVS Pharma Ltd has increased, indicating rising retail investor interest.
Bliss GVS Pharma Ltd Government Holding
Government holding in Bliss GVS Pharma Ltd currently stands at 0%.
Bliss GVS Pharma Ltd operates without significant government ownership.
Bliss GVS Pharma Ltd Shareholding Analysis Summary
The Bliss GVS Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Bliss GVS Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Bliss GVS Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.